NF
NAP B.V. ForGrowth (10% owner) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $4.1M of NAMS (157,234 sh across 3 lots, as filed), executed Dec 18 2024. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.8M
shares × price, as filed
Last traded
Dec 30 2024
Filed Jan 2 2025
Median ADV $32.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 24 months
Most traded names
NAMSRecent filings
NAMSSALE
NewAmsterdam Pharma Company N.V.
View filing →
$762K29,846 sh × $25.54
Exec Dec 30 2024
Filed Jan 2 2025 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $4.1M
157,234 sh across 3 lots
Exec Dec 18 2024
Filed Dec 20 2024 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $1.0M
41,803 sh across 2 lots
Exec Nov 15 2024
Filed Nov 19 2024 · 5:30 PM ET